Abstract
Vast arrays of medications have been used, with limited success, to manage stuttering. Haloperidol and risperidone are the only two medications that have shown efficacy via double-blind studies in controlling stuttering symptoms. We present the first case reports of olanzapine in the management of stuttering. Three case histories are presented: a 10-year-old boy, a 16-year-old male adolescent with developmental stuttering, and a 9-year-old boy with medication-induced stuttering whose symptoms are successfully controlled with olanzapine. These case studies suggest that olanzapine may be a pharmacologic option in the management of stuttering.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV). Washington, D.C.: American Psychiatric Association; 1994
Leung AK, Robson LM: Stuttering. Clin Pediatr 1990; 29:498–502
Andrews G, Craig A, Feyer AM, Hoddinott S, Howie P, Neilson M: Stuttering: a review of research findings and circa 1982. J Speech Hear Disord 1983; 48:226–246
Cooper EB: Etiology and treatment of stuttering. Ear Nose Throat J 1980; 59:60–61, 76–81
Wu JC, Maguire G, Riley G, Lee A, Keator D, Tang C, Fallon J, Najafi A: Increased dopamine activity associated with stuttering. Neuroreport 1997; 8:767–770
Rosenberger PB: Dopaminergic systems and speech fluency. J Fluency Disord. 1980; 5:255–267
Burd L, Kerbeshian J: Stuttering and stimulants (letter). J Clin Psychopharmacol 1991; 11:72–73
Brady JP: The pharmacology of stuttering: a critical review. Am J Psychiatry 1991; 148:1309–1316
Maguire GA, Gottschalk LA, Riley GD, Franklin DL: Risperidone in the treatment of stuttering. J Clin Psychopharmacol 1999, (in press)
Murray TJ, Kelly P, Campbell L, Stefanik K: Haloperidol in the treatment of stuttering. Br J Psychiatry 1977; 130:370–373
Kando JC, Shepski JC, Satterlee W, Patel JK, Reams SG, Green AI: Olanzapine: a new antipsychotic agent with efficacy in the management of schizophrenia. Ann Pharmacother 1997; 31:1325–1334
Toren P, Laor N, Weizman A: Use of atypical neuroleptics in child and adolescent psychiatry. J Clin Psychiatry 1998; 59:644–656
Tran PV, Hamilton SH, Kuntz AJ, Potvin JH, Anderson SW, Beasley C, Tollefson GD: Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol 1997; 17:407–418
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lavid, N., Franklin, D.L. & Maguire, G.A. Management of Child and Adolescent Stuttering with Olanzapine: Three Case Reports. Ann Clin Psychiatry 11, 233–236 (1999). https://doi.org/10.1023/A:1022365513865
Issue Date:
DOI: https://doi.org/10.1023/A:1022365513865